<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Bone Metabolism News</title> 
<link>http://www.mdlinx.com/EndoLinx/news.cfm/newspage/1/spec_id/16/subspec_id/412</link> 
<description>Bone Metabolism</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>









<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 



<item> 
<title><![CDATA[Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2960199</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Osteoporosis International</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2960199</guid>
</item> 
 

<item> 
<title><![CDATA[Risk factors for osteoporosis in healthy males]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2963381</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Central European Journal of Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2963381</guid>
</item> 
 

<item> 
<title><![CDATA[Prevalent vertebral deformity independently increases incident vertebral fracture risk in middle-aged and elderly Japanese women: The Japanese Population-based Osteoporosis (JPOS) Cohort Study]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2960194</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Osteoporosis International</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2960194</guid>
</item> 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 

<item> 
<title><![CDATA[Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2960200</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Osteoporosis International</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2960200</guid>
</item> 
 

<item> 
<title><![CDATA[Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/beta-catenin signaling pathway]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2962804</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Molecular and Cellular Endocrinology</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2962804</guid>
</item> 
 
 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
  


</channel> 
</rss>

